We are live on ! Find out more
Royal Bank of Canada

Royal Bank of Canada Portfolio holdings

AUM $570B
1-Year Est. Return 27.57%
 

Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.

This Fund
S&P 500
This Quarter Est. Return
+4.82%
1 Year Est. Return
+27.57%
3 Year Est. Return
+75.99%
5 Year Est. Return
+94.97%
10 Year Est. Return
+325.25%
AUM
$228B
AUM Growth
+$19.5B
Cap. Flow
+$9.66B
Cap. Flow %
4.24%
Top 10 Hldgs %
19.68%
Holding
7,447
New
331
Increased
2,461
Reduced
3,156
Closed
486

Sector Composition

Rank Sector Weight
1 Financials 21.58%
2 Energy 8.65%
3 Industrials 8.54%
4 Technology 7.61%
5 Communication Services 7.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNVS icon
6451
Cineverse
CNVS
$69.7M
0
COHN icon
6452
Cohen & Co
COHN
$38.4M
-40
Closed
COOP
6453
DELISTED
Mr. Cooper
COOP
$0 ﹤0.01%
46
-1,466
-97% -$14.1K
COST icon
6454
CALL
Costco
COST
$423B
-13,800
Closed -$2.27M
CPIX icon
6455
Cumberland Pharmaceuticals
CPIX
$116M
-3
Closed
CPSH icon
6456
CPS Technologies
CPSH
$85.1M
$0 ﹤0.01%
7
CRD.B icon
6457
Crawford & Co Class B
CRD.B
$583M
$0 ﹤0.01%
17
-1,091
-98% -$11.6K
CRDF icon
6458
Cardiff Oncology
CRDF
$80.1M
-3
Closed -$133
CRESY
6459
Cresud
CRESY
$754M
$0 ﹤0.01%
4
CRMD icon
6460
CorMedix
CRMD
$621M
$0 ﹤0.01%
6
CRT
6461
Cross Timbers Royalty Trust
CRT
$60.1M
$0 ﹤0.01%
+11
New +$163
CRVO icon
6462
CervoMed
CRVO
$40.6M
0
CSIQ icon
6463
PUT
Canadian Solar
CSIQ
$1.04B
-300,000
Closed -$5.05M
CSPI icon
6464
CSP Inc
CSPI
$85.6M
$0 ﹤0.01%
2
CTRA
6465
CALL
DELISTED
Coterra Energy
CTRA
-59,700
Closed -$1.6M
CTRA
6466
PUT
DELISTED
Coterra Energy
CTRA
-231,400
Closed -$6.19M
CTRN icon
6467
CALL
Citi Trends
CTRN
$627M
-100,000
Closed -$1.99M
CTRN icon
6468
PUT
Citi Trends
CTRN
$627M
-100,000
Closed -$1.99M
CUBI icon
6469
Customers Bancorp
CUBI
$2.83B
$0 ﹤0.01%
9
-2,467
-100% -$70K
CVGI icon
6470
Commercial Vehicle Group
CVGI
$129M
-2,223
Closed -$16K
CVM icon
6471
CEL-SCI Corp
CVM
$25.5M
$0 ﹤0.01%
9
+1
+13% +$54
CVNA icon
6472
Carvana
CVNA
$82B
-3,006,490
Closed -$8.83M
CVV icon
6473
CVD Equipment Corp
CVV
$53.9M
$0 ﹤0.01%
1
BGMS
6474
Bio Green Med Solution Inc
BGMS
$5.06M
0
CZWI icon
6475
Citizens Community Bancorp
CZWI
$203M
$0 ﹤0.01%
1

Similar funds

Royal Bank of Canada's Q4 2017 Portfolio in Review

As of Q4 2017, Royal Bank of Canada held 7,447 positions worth $228B, up 9.4% from $208B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Royal Bank of Canada deployed $9.66B of net new capital in Q4 2017, opening 331 new positions and adding to 2,461 existing holdings. Its largest new stake was Maxar Technologies Inc. Common Stock: 2,562,561 shares worth $165M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 22% a quarter earlier, followed by Energy and Industrials.

On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $611M trimmed.

  • Royal Bank of Canada's largest Q4 2017 buy was Maxar Technologies Inc. Common Stock: 2,562,561 shares worth $165M.
  • Royal Bank of Canada added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $2.31B increase.
  • Royal Bank of Canada's biggest Q4 2017 reduction was iShares Core S&P 500 ETF, cutting an estimated $611M.
  • Royal Bank of Canada fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $144M.
  • Royal Bank of Canada's ten largest holdings make up 20% of its $228B portfolio in Q4 2017.
  • Royal Bank of Canada opened 331 new positions and closed 486 in Q4 2017.
  • Royal Bank of Canada's portfolio value rose 9.4% quarter-over-quarter to $228B.

Based on Royal Bank of Canada's 13F filing for Q4 2017, filed 14 Feb 2018.